Clinical Trials

150 enrolled

Lymphoma, Extranodal NK-T-Cell

NCT07387926 2026-02-04

Safety and Efficacy of Asciminib in Pediatrics and Young Adults With Relapse/Refractory (r/r) Philadelphia Positive (Ph+) or ABL-class Ph-like Acute Lymphoblastic Leukemia (ALL)

50 enrolled

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT07180771 2026-01-28

A Study of Bosmolisib (BR101801) in Participants With R/R PTCL.

44 enrolled

Lymphoma, T-Cell, Peripheral

NCT07360288 2026-01-22

TC011_FL_201

40 enrolled

Lymphoma, Follicular

NCT07024706 2026-01-21

MAVRiC

80 enrolled

Leukemia, Lymphocytic, Chronic, B-Cell

NCT07342478 2026-01-16

ROCKET-CLL Global Phase 3 Study: Rocbrutinib vs Pirtobrutinib in cBTKi-Pretreated R/R CLL/SLL

306 enrolled

Chromosome 17 deletion, Recurrence, Leukemia, B-Cell, Leukemia, Lymphocytic, Chronic, B-Cell

NCT07333469 2026-01-13

A Clinical Study of HX111 in Patients With Advanced Solid Tumor and Lymphoma

70 enrolled

Lymphoma

NCT06985576 2025-12-18

Long-term Study to Evaluate Safety and Persistence of GF-CART01

18 enrolled

LymphoidSarcoma

Lymphoma, Follicular, Dendritic Cell Sarcoma, Interdigitating

NCT07244380 2025-11-24

Phase II Trial of S101 Autologous Anti-CD7 CAR-T Cells in Patients With R/R T-LBL/ALL.

38 enrolled

Lymphoma

NCT06970496 2025-11-20

A Clinical Trial of B019 Injection in Patients With Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma.

48 enrolled

Recurrence, Lymphoma, B-Cell

NCT06979076 2025-09-29

A Phase Ib Study of the Selective PKC-β Inhibitor MS-553 in Patients With Refractory or Relapsed CLL/SLL

12 enrolled

Phase EARLY_PHASE1 Not yet recruiting

Leukemia, B-Cell, Leukemia, Lymphocytic, Chronic, B-Cell

NCT07196111 2025-09-29

BAFFR CAR-T Treatment for Relapsed/Refractory B-cell Tumors

12 enrolled

Burkitt Lymphoma, Lymphoma

NCT07192471 2025-09-25

A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma

72 enrolled

DermatologicLymphoid

Immune System Diseases, Lymphoma, Mycosis Fungoides, Neoplasms, Sezary Syndrome, Lymphoma, T-Cell, Cutaneous, Lymphoma, T-Cell, Peripheral

NCT07187960 2025-09-23

Evaluation of the Efficacy and Safety of TQB2825 Injection Compared to Immunotherapy in the Treatment of Recurrent/Refractory Follicular Lymphoma

228 enrolled

Lymphoma, Follicular

NCT07107204 2025-09-17

A Clinical Study of BT02 in Patients With Relapsed or Refractory Hematologic Malignancies

LymphoidOther hematologic neoplasmPlasma cell

116 enrolled

Leukemia, Lymphoma, Multiple Myeloma, Recurrence, Hematologic Neoplasms

NCT07035379 2025-08-22

A Phase I/II Study of TRS005 in Combination With Cyclophosphamide, Doxorubicin, and Prednisone（T-CHP） in Previously Untreated Patients With CD20-positive DLBCL

66 enrolled

Lymphoma, Large B-Cell, Diffuse

NCT07099079 2025-08-01

Post-Market Clinical Follow-Up Study on the Rotational Stability of an Intraocular Lens After Cataract Surgery

92 enrolled

Cataract, Intraocular Lymphoma

NCT07092852 2025-07-30

PGx Medication Safety Reviews of Persons With IDD

700 enrolled

Developmental Disabilities, Lymphoma, Follicular, Intellectual Disability

NCT06385522 2025-07-08

A Clinical Trial in Adults With Non-Hodgkin Lymphoma (NHL), With a Particular Emphasis on Cutaneous T Cell Lymphoma (CTCL), Testing the Safety and Activity of a Novel Drug to Inhibit a Protein Called Tumor Necrosis Factor Receptor 2 That Drives Both Lymphoma Growth and Escape of the Immune System

Phase EARLY_PHASE1 Not yet recruiting

37 enrolled

DermatologicLymphoid

Lymphoma, T-Cell, Cutaneous, Lymphoma, T-Cell, Peripheral

NCT07048353 2025-07-02

CAR-T，MTD

15 enrolled

Phase NA Not yet recruiting

Lymphoma, Lymphoma, B-Cell

NCT07011966 2025-06-10

ASV Therapy for Insomnia

25 enrolled

Phase EARLY_PHASE1 Not yet recruiting

Sleep Initiation and Maintenance Disorders, Lymphoma, Follicular

NCT07003178 2025-06-04

A Study to Evaluate the Safety and Clinical Efficacy of STR-P004

30 enrolled

Lymphoma, Non-Hodgkin

NCT06894693 2025-03-25

A Phase I Clinical Trial of RS001 in Patients with Relapsed/Refractory B-Cell Malignancies

13 enrolled

Lymphoma, B-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT06845241 2025-02-25

Evaluate the Safety, Tolerability, and Efficacy of ICP-490 in Patients with Relapsed or Refractory Non-Hodgkin Lymphoma

68 enrolled

Lymphoma, Non-Hodgkin, Recurrence

NCT06702605 2024-11-25

To Evaluate XNW5004 Tablets in Patients with Relapsed or Refractory Peripheral T Cell Lymphoma

50 enrolled

Lymphoma, T-Cell, Peripheral

NCT06641024 2024-10-15

Clinical Research of CD19 Targeted CAR-T Cell in Relapsed/ Refractory B-ALL

24 enrolled

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT06323447 2024-10-09

PC002

Phase 2/3 Not yet recruiting

210 enrolled

LymphoidPlasma cell

Multiple Myeloma, Lymphoma, Large B-Cell, Diffuse

NCT06548347 2024-08-12

A Phase II/III Study of Linperlisib Plus CHOP Versus CHOP in Patients With Newly Diagnosed Peripheral T Cell Lymphoma

606 enrolled

Lymphoma, T-Cell, Peripheral

NCT06434467 2024-05-30

The Efficacy and Safety of Nelarabine Injection in Patients With T-lymphoblastic Leukemia and T-lymphoblastic Lymphoma

83 enrolled

Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

NCT06367114 2024-04-19

Clinical Trial of ssCART-19 Cell Injection in the Treatment of Relapsed or Refractory Acute Lymphoblastic Leukemia (Including Central Nervous System Infiltration)

50 enrolled

Recurrence, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT06368167 2024-04-16

A Phase II Study of SHR2554 in Patients With Relapsed or Refractory Follicular Lymphoma

105 enrolled

Phase NA Not yet recruiting

Lymphoma, Follicular

NCT06363201 2024-04-12

Effect and Safety of Ocoxin Oral Solution on the Quality of Life of Paediatric Patients With Advanced Stage Solid Tumours

40 enrolled

CNSLymphoidSarcoma

Hodgkin Disease, Neoplasms, Neoplasms, Germ Cell and Embryonal, Sarcoma, Central Nervous System Neoplasms

NCT05545202 2024-04-03

A Randomized, Comparative, Double-blind Trial of Pentaisomaltose and Dimethyl Sulphoxide for Cryoprotection of Hematopoietic Stem Cells in Subjects With Multiple Myeloma or Malignant Lymphoma With a Need for Autologous Transplantation

Phase 4 Not yet recruiting

150 enrolled

LymphoidPlasma cell

Lymphoma, Multiple Myeloma

NCT06318884 2024-03-22

A First-in-human Study of SCTB35 in Patients With Relapse/Refractory B-cell Non-Hodgkin Lymphoma

76 enrolled

Lymphoma, Non-Hodgkin

NCT06314828 2024-03-18

A Tolerability, Safety and Efficacy Study of RJMty19 in Subjects With Relapsed or Refractory B-NHL

30 enrolled